TipRanks
Go Ultimate55% OFF

Iovance Biotherapeutics (0JDK) Balance Sheet

Iovance Biotherapeutics Balance Sheet

Iovance Biotherapeutics's total assets for Q2 2026 were $915.53M, a decrease of 1.09% from the previous quarter. GB:0JDK total liabilities were $179.49M for the fiscal quarter, a 11.98% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
$ 913.17M$ 910.43M$ 780.35M$ 663.98M$ 777.33M
$ 214.59M$ 200.02M$ 195.74M$ 164.34M$ 155.67M
$ 698.58M$ 710.40M$ 584.61M$ 499.64M$ 621.66M

Currency in USD

Iovance Biotherapeutics Debt to Assets

0400M800M1.2B0 %10 %20 %30 %LiabilitiesDebt to Assets201720182019202020212022202320242025AssetsLiabilitiesDebt to Assets